Biblio

Export 791 results:
[ Author(Asc)] Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
X
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers., J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
Z. - Q. Xu, Huang, H., Chen, Y. - L., Gao, Y. - Y., Xu, J., Marshall, C., Cai, Z. - Y., and Xiao, M., Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis., J Alzheimers Dis, vol. 51, no. 1, pp. 179-95, 2016.
Y. Xu, Zheng, F., Zhong, Q., and Zhu, Y., Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer's Disease: Mechanisms and Clinical Implications., J Alzheimers Dis, vol. 92, no. 4, pp. 1173-1198, 2023.
L. Xiong, Davidsdottir, S., Reijmer, Y. D., Shoamanesh, A., Roongpiboonsopit, D., Thanprasertsuk, S., Martinez-Ramirez, S., Charidimou, A., Ayres, A. M., Fotiadis, P., Gurol, E., Blacker, D. L., Greenberg, S. M., and Viswanathan, A., Cognitive Profile and its Association with Neuroimaging Markers of Non-Demented Cerebral Amyloid Angiopathy Patients in a Stroke Unit., J Alzheimers Dis, vol. 52, no. 1, pp. 171-8, 2016.
M. Xie, Han, Y., Yu, Q., Wang, X., Wang, S., and Liao, X., UCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein., J Alzheimers Dis, vol. 49, no. 2, pp. 353-63, 2016.
H. Xie, Zhang, C., Wang, Y., Huang, S., Cui, W., Yang, W., Koski, L., Xu, X., Li, Y., Zheng, M., He, M., Fu, J., Shi, X., Wang, K., Tang, G., Wang, B., and Huo, Y., Distinct Patterns of Cognitive Aging Modified by Education Level and Gender among Adults with Limited or No Formal Education: A Normative Study of the Mini-Mental State Examination., J Alzheimers Dis, vol. 49, no. 4, pp. 961-9, 2016.
W
W. Wu, Lee, I., Spratt, H., Fang, X., and Bao, X., tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms., J Alzheimers Dis, vol. 79, no. 2, pp. 793-806, 2021.
L. Wu, Liu, J., Feng, X., Dong, J., Qin, W., Liu, Y., Wang, J., Lu, J., Chen, K., Wang, Y., and Jia, J., 11C-CFT-PET in Presymptomatic FTDP-17: A Potential Biomarker Predicting Onset., J Alzheimers Dis, vol. 61, no. 2, pp. 613-618, 2018.
Y. Wu and Eisel, U. L. M., Microglia-Astrocyte Communication in Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 3, pp. 785-803, 2023.
C. Wu, Ma, Y. - H., Hu, H., Zhao, B., and Tan, L., Soluble TREM2, Alzheimer's Disease Pathology, and Risk for Progression of Cerebral Small Vessel Disease: A Longitudinal Study., J Alzheimers Dis, vol. 92, no. 1, pp. 311-322, 2023.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
W. Wruck, Schröter, F., and Adjaye, J., Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer's Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks., J Alzheimers Dis, vol. 50, no. 4, pp. 1065-82, 2016.
C. B. Wright, DeRosa, J. T., Moon, M. P., Strobino, K., DeCarli, C., Cheung, Y. Kuen, Assuras, S., Levin, B., Stern, Y., Sun, X., Rundek, T., Elkind, M. S. V., and Sacco, R. L., Race/Ethnic Disparities in Mild Cognitive Impairment and Dementia: The Northern Manhattan Study., J Alzheimers Dis, vol. 80, no. 3, pp. 1129-1138, 2021.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
C. N. Winston, Langford, O., Levin, N., Raman, R., Yarasheski, K., West, T., Abdel-Latif, S., Donohue, M., Nakamura, A., Toba, K., Masters, C. L., Doecke, J., Sperling, R. A., Aisen, P. S., and Rissman, R. A., Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
A. Winkler, Weimar, C., Jöckel, K. - H., Erbel, R., Dragano, N., Broecker-Preuss, M., Moebus, S., Führer-Sakel, D., and Dlugaj, M., Thyroid-Stimulating Hormone and Mild Cognitive Impairment: Results of the Heinz Nixdorf Recall Study., J Alzheimers Dis, vol. 49, no. 3, pp. 797-807, 2016.
A. Wimo, Sjölund, B. - M., Sköldunger, A., Qiu, C., Klarin, I., Nordberg, G., and von Strauss, E., Cohort Effects in the Prevalence and Survival of People with Dementia in a Rural Area in Northern Sweden., J Alzheimers Dis, vol. 50, no. 2, pp. 387-96, 2016.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial., J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
M. T. White, Shaw, L. M., and Xie, S. X., Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
W. Wharton, Goldstein, F. C., Tansey, M. G., Brown, A. L., Tharwani, S. D., Verble, D. D., Cintron, A., and Kehoe, P. G., Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial., J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
A. M. Wessels, Belger, M., Johnston, J. A., Yu, Y., Rentz, D. M., Dowsett, S. A., and Chandler, J., Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes., J Alzheimers Dis, vol. 88, no. 2, pp. 577-588, 2022.
E. X. Wei, Oh, E. S., Harun, A., Ehrenburg, M., and Agrawal, Y., Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 995-1003, 2018.

Pages